Insider Transactions in Q3 2022 at Reneo Pharmaceuticals, Inc. (RPHM)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2022
|
Michael Cruse Chief Operating Officer |
BUY
Open market or private purchase
|
Indirect |
7,500
+35.38%
|
$22,500
$3.39 P/Share
|
|
Aug 31
2022
|
Michael G Grey |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$50,000
$1.97 P/Share
|
|
Aug 31
2022
|
Michael Cruse Chief Operating Officer |
BUY
Open market or private purchase
|
Indirect |
3,212
+34.14%
|
$9,636
$3.21 P/Share
|
|
Aug 30
2022
|
Michael Cruse Chief Operating Officer |
BUY
Open market or private purchase
|
Indirect |
1,845
+38.2%
|
$5,535
$3.19 P/Share
|
|
Aug 30
2022
|
Michael Cruse Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
975
+2.98%
|
$2,925
$3.16 P/Share
|
|
Aug 29
2022
|
Michael Cruse Chief Operating Officer |
BUY
Open market or private purchase
|
Indirect |
1,140
+50.0%
|
$3,420
$3.24 P/Share
|
|
Aug 29
2022
|
Michael Cruse Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
83
+0.27%
|
$249
$3.24 P/Share
|
|
Aug 12
2022
|
Alejandro Dorenbaum Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
22,348
-42.69%
|
-
|